Madsen L - Search Results

1

Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity.

Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, Kristiansen K, Frøyland L, Hibbeln JR. Alvheim AR, et al. Among authors: madsen l. Obesity (Silver Spring). 2012 Oct;20(10):1984-94. doi: 10.1038/oby.2012.38. Epub 2012 Feb 15. Obesity (Silver Spring). 2012. PMID: 22334255 Free PMC article.

2

Up-regulated delta 9-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: accumulation of a delta 9-desaturated metabolite of tetradecylthioacetic acid.

Madsen L, Frøyland L, Grav HJ, Berge RK. Madsen L, et al. J Lipid Res. 1997 Mar;38(3):554-63. J Lipid Res. 1997. PMID: 9101436 Free article.

3

Effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart.

Frøyland L, Madsen L, Sjursen W, Garras A, Lie O, Songstad J, Rustan AC, Berge RK. Frøyland L, et al. Among authors: madsen l. J Lipid Res. 1997 Aug;38(8):1522-34. J Lipid Res. 1997. PMID: 9300774 Free article.

4

Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism.

Frøyland L, Madsen L, Vaagenes H, Totland GK, Auwerx J, Kryvi H, Staels B, Berge RK. Frøyland L, et al. Among authors: madsen l. J Lipid Res. 1997 Sep;38(9):1851-8. J Lipid Res. 1997. PMID: 9323594 Free article.

5

Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation.

Madsen L, Frøyland L, Dyrøy E, Helland K, Berge RK. Madsen L, et al. J Lipid Res. 1998 Mar;39(3):583-93. J Lipid Res. 1998. PMID: 9548590 Free article.

6

Carnitine palmitoyltransferase I, carnitine palmitoyltransferase II, and acyl-CoA oxidase activities in Atlantic salmon (Salmo salar).

Frøyland L, Madsen L, Eckhoff KM, Lie O, Berge RK. Frøyland L, et al. Among authors: madsen l. Lipids. 1998 Sep;33(9):923-30. doi: 10.1007/s11745-998-0289-4. Lipids. 1998. PMID: 9778140

7

The mitochondrion is the principal target for nutritional and pharmacological control of plasma triglyceride.

Madsen L, Frøyland L, Kryvi H, Auwerx J, Staels B, Berge RK. Madsen L, et al. Lipids. 1999;34 Suppl:S167. doi: 10.1007/BF02562277. Lipids. 1999. PMID: 10419137 No abstract available.

8

The 3-thia fatty acid, a novel bioactive compound, which changes the plasma profile from atherogenic to cardioprotective.

Berge RK, Madsen L, Frøyland L. Berge RK, et al. Among authors: madsen l. Lipids. 1999;34 Suppl:S201. doi: 10.1007/BF02562289. Lipids. 1999. PMID: 10419149 No abstract available.

9

Methylated eicosapentaenoic acid and tetradecylthioacetic acid: effects on fatty acid metabolism.

Vaagenes H, Madsen L, Dyrøy E, Elholm M, Stray-Pedersen A, Frøyland L, Lie O, Berge RK. Vaagenes H, et al. Among authors: madsen l. Biochem Pharmacol. 1999 Oct 1;58(7):1133-43. doi: 10.1016/s0006-2952(99)00198-7. Biochem Pharmacol. 1999. PMID: 10484071

10

The hypolipidaemic effect of EPA is potentiated by 2- and 3-methylation.

Vaagenes H, Madsen L, Dyrøy E, Frøyland L, Willumsen N, Berge RK. Vaagenes H, et al. Among authors: madsen l. Adv Exp Med Biol. 1999;466:221-6. doi: 10.1007/0-306-46818-2_26. Adv Exp Med Biol. 1999. PMID: 10709648 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

780 results

Search Page

Filters